Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Rockwell Medical (RMTI) EBIT Margin (2016 - 2025)

Historic EBIT Margin for Rockwell Medical (RMTI) over the last 17 years, with Q3 2025 value amounting to 9.95%.

  • Rockwell Medical's EBIT Margin fell 167800.0% to 9.95% in Q3 2025 from the same period last year, while for Sep 2025 it was 6.37%, marking a year-over-year decrease of 69500.0%. This contributed to the annual value of 0.6% for FY2024, which is 85800.0% up from last year.
  • According to the latest figures from Q3 2025, Rockwell Medical's EBIT Margin is 9.95%, which was down 167800.0% from 8.39% recorded in Q2 2025.
  • In the past 5 years, Rockwell Medical's EBIT Margin registered a high of 6.84% during Q3 2024, and its lowest value of 54.52% during Q4 2021.
  • In the last 5 years, Rockwell Medical's EBIT Margin had a median value of 9.95% in 2025 and averaged 18.39%.
  • As far as peak fluctuations go, Rockwell Medical's EBIT Margin surged by 443400bps in 2022, and later tumbled by -167800bps in 2025.
  • Rockwell Medical's EBIT Margin (Quarter) stood at 54.52% in 2021, then surged by 81bps to 10.18% in 2022, then surged by 76bps to 2.48% in 2023, then rose by 15bps to 2.1% in 2024, then crashed by -373bps to 9.95% in 2025.
  • Its EBIT Margin was 9.95% in Q3 2025, compared to 8.39% in Q2 2025 and 7.19% in Q1 2025.